Skip to content

Characterization and Analysis of Evoked Cortical Responses in Participants With Medication-intractable Epilepsy

Characterization and Analysis of Evoked Cortical Responses in Participants With Medication-intractable Epilepsy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07014592
Enrollment
5
Registered
2025-06-11
Start date
2025-05-05
Completion date
2028-06-01
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intractable Epilepsy

Brief summary

The goal of this project is to study how the brain reacts to a small electrical signal. Researchers will be using a novel combination of recording electrodes. The researchers will measure the brain response from these electrodes.

Interventions

DEVICEstimulating probes and electrodes

Subdural electrodes and/or ball tip probes will be used intraoperatively to provide electrical stimulation to the brain.

Sponsors

University of Michigan
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
22 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Patients with medication intractable epilepsy who are recommended to undergo brain surgery to remove a "seizure" focus * Can provide informed consent for the study and willing to participate

Exclusion criteria

* Presence of a permanent electronic implant * Any chronic medical conditions that prevent safe placement of electrodes

Design outcomes

Primary

MeasureTime frameDescription
Characterization of time-frequency dataDuring a 20 minute research phase of a clinically indicated surgeryFrom recording electrodes
Characterization of local field responses (LFPs)During a 20 minute research phase of a clinically indicated surgeryFrom recording electrodes

Countries

United States

Contacts

CONTACTRon Ball
rmball@umich.edu734 936-7010
PRINCIPAL_INVESTIGATORMatthew Willsey, MD, PhD

University of Michigan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 9, 2026